Drug General Information
Drug ID
D05QTJ
Former ID
DNC000423
Drug Name
Chloroethylclonidine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [537921]
Structure
Download
2D MOL

3D MOL

Formula
C13H17Cl3N4
Canonical SMILES
CN(CCCl)CC1=CC(=C(C(=C1)Cl)NC2=NCCN2)Cl
InChI
1S/C13H17Cl3N4/c1-20(5-2-14)8-9-6-10(15)12(11(16)7-9)19-13-17-3-4-18-13/h6-7H,2-5,8H2,1H3,(H2,17,18,19)
InChIKey
XFDVJGKSQRUEEM-UHFFFAOYSA-N
CAS Number
CAS 98086-36-3
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Alpha-2A adrenergic receptor Target Info Agonist [537921]
Alpha-2C adrenergic receptor Target Info Agonist [537921]
KEGG Pathway cGMP-PKG signaling pathway
Neuroactive ligand-receptor interactionhsa04022:cGMP-PKG signaling pathway
Neuroactive ligand-receptor interaction
PANTHER Pathway Alpha adrenergic receptor signaling pathwayP00002:Alpha adrenergic receptor signaling pathway
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
Reactome Adrenoceptors
Adrenaline signalling through Alpha-2 adrenergic receptor
Adrenaline,noradrenaline inhibits insulin secretion
G alpha (i) signalling events
G alpha (z) signalling events
Surfactant metabolismR-HSA-390696:Adrenoceptors
Surfactant metabolism
WikiPathways Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
Platelet Aggregation (Plug Formation)
Integration of energy metabolism
GPCR ligand binding
GPCR downstream signalingWP58:Monoamine GPCRs
GPCR downstream signaling
References
Ref 537921Selective irreversible binding of chloroethylclonidine at alpha 1- and alpha 2-adrenoceptor subtypes. Mol Pharmacol. 1993 Dec;44(6):1165-70.
Ref 537921Selective irreversible binding of chloroethylclonidine at alpha 1- and alpha 2-adrenoceptor subtypes. Mol Pharmacol. 1993 Dec;44(6):1165-70.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.